Journal of Brain Tumors is a peer-reviewed open-access journal focused to publish articles related to benign and malignant tumors. Also emphasized to publish literature of Brain tumors that begin in the brain i,e primary brain tumors, and cancer that begin in other parts of the body and spread to the brain i,e secondary brain tumors. Through this journal, readers will have immediate access to all cases, methodical and conceptual data about brain tumor types, stages, causes, signs and symptoms, diagnosis, prognosis and survival rate, treatment for brain malignancies, and tumors. We publish high-quality articles via open-access platform and is greatly supported by invaluable contributions from the world-class eminent experts in the field by justifying the scientific validity of the selective published content.
The Journal encourages developing an optimized knowledge-sharing platform and an enlightening interactive network for researchers to share, promote, and contribute the latest research in brain tumors. All the Published content is made accessible with no restriction barriers under Creative Common Attribution License.Journal of Brain tumors welcomes original, reviews, case reports, clinical images, communications, commentaries, opinions, short notes, and perspectives bringing novel insights and research highlights in the field.
Director
Neuroradiology and Research
LSU Health Sciences Center Shreveport
United States of America
Tel: 318- 573-3629
Clinical Professor
Medical College of Wisconsin
Medical School Regional Campus–Central Wisconsin
United States of America
Tel: 847-251-6760
Professor
Department of Research and Cancer Biology
Mayo Clinic Arizona
United States of America
Director
Promab Biotechnologies
Richmond, California
United States of America
Tel: 352-262-4846
Professor, Deputy Director
State Local Joint Engineering Laboratory for Anticancer Drugs
Xiangya Hospital
Central South University, China
Tel: 86-731-84327905
Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct
Original Article
PERNO study enrolled for a three-year period every person living in Emilia-Romagna Region with a new diagnosis of primary brain tumor (PBT). We previo... Read more
